Last checked at 2 Dec 2022 10:40
AIM WINNERS & LOSERS: Orosur Mining drops on disappointing assays
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Reneuron Share News (RENE)
RENE Share
Price
RENE Share
News
RENE Share
Chat
RENE Share
Trades
RENE
Live RNS
RENE Share
Charts
RENE Level 2
Console
RENE Live
Share Price
RENE Broker
Ratings
RENE Directors
Deals
RENE Financial
Diary
RENE
Fundamentals
RENE Short
Positions
RENE
Media
Reneuron Information
- This share is currently suspended. It was suspended at a price of 3.275
Share Price Information for Reneuron (RENE)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
3.275
Bid:
0.00
Ask:
0.00
Change:
0.00 (0.00%)
Spread:
0.00 (0.00%)
Open:
0.00
High:
0.00
Low:
0.00
Prev. Close:
3.275
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.ReNeuron Group wins grants for stem cell therapy development
Mon, 11th Mar 2013 08:31
ReNeuron Group has won two grants worth 1.2m pounds to develop its stem cell therapy. The grants were awarded by the UK Biomedical Catalyst, a programme of public funding jointly managed by the Technology Strategy Board and the Medical Research Council. The first award of £0.4m will be used for ReNeuron's ReN009 stem cell therapy candidate for critical limb ischaemia, a severe blockage in the arteries which markedly reduces blood-flow to the extremities including hands, feet and legs. The second award of £0.8m relates to the company's ReN003 stem cell candidate for the treatment of retinitis pigmentosa, an eye disease in which there is damage to the retina.Michael Hunt, the Chief Executive Officer of ReNeuron, said: "We are delighted to have been successful in winning the two grants we applied for in the current round of the Biomedical Catalyst funding competition. "This highly competitive scheme involves a rigorous peer review of applicants' technologies and commercial development plans. "In common with other awardees, we therefore regard the grants as representing a strong independent endorsement of ReNeuron's world-class stem cell development capabilities which we hope will eventually lead to the wide-scale treatment of disease conditions where there is currently a very large unmet medical need."Shares rose 0.86% to 2.94p at 08:52 Monday.RD
More News
2 Dec 2022 09:31
ReNeuron loss narrows amid lower costs and surging revenue
(Alliance News) - ReNeuron Group PLC on Friday said its loss narrowed in the first half of its financial year, following lower costs, increased revenue and foreign exchange gains.
Read more7 Oct 2022 10:32
ReNeuron says exosomes outperform alternatives at Boston summit
(Alliance News) - ReNeuron Group PLC on Friday said it presented positive new data at a leading summit of targeted therapies.
Read more14 Sep 2022 13:19
IN BRIEF: ReNeuron promotes Financial Controller Hawkins to CFO
ReNeuron Group PLC - Bridgend, Wales-based stem cell and exosomes technology company - Promotes Financial Controller John Hawkins to chief financial officer with immediate effect. Hawkins joined the company in 2014 as financial controller and was also named as the company secretary last year. Says Hawkins is an experienced finance professional with a breadth of experience gained within "a variety of businesses, from large PLCs to family-owned SMEs".
Read more2 Sep 2022 15:57
UK shareholder meetings calendar - next 7 days
| Monday 5 September | |
| Highway Capital PLC | AGM |
| Hill & Smith Holdings PLC | AGM |
| Hydrogen Utopia International PLC | AGM |
| LXi REIT PLC | AGM |
| Monks Investment Trust PLC | AGM |
| Totally PLC | AGM |
| Tuesday 6 September | |
| Ashtead Group PLC | AGM |
| Berkeley Group Holdings PLC | AGM |
| Brickability Group PLC | AGM |
| Castelnau Group Ltd | AGM |
| DS Smith PLC | AGM |
| Lamprell PLC | AGM |
| Renold PLC | AGM |
| Wednesday 7 September | |
| BlueRock Diamonds PLC | AGM |
| CVC Income & Growth Ltd | EGM |
| Halfords Group PLC | AGM |
| Jupiter Green Investment Trust PLC | AGM |
| Mulberry Group PLC | AGM |
| Okyo Pharma Ltd | AGM |
| Polar Capital Holdings PLC | AGM |
| Redcentric PLC | AGM |
| Seed Innovations Ltd | AGM |
| Trifast PLC | AGM |
| Yellow Cake PLC | AGM |
| Thursday 8 September | |
| Atlantis Japan Growth Fund Ltd | AGM |
| Aston Martin Lagonda Global Holdings PLC | GM proposed equity capital raise |
| Caretech Holdings PLC | GM takeover by Sheikh Holdings Group |
| Chariot Ltd | AGM |
| Chelverton UK Dividend Trust PLC | AGM |
| Currys PLC | AGM |
| Euromoney Institutional Investor PLC | GM re takeover offer by Astorg and Epiris |
| Gabelli Merger Plus+ Trust PLC | GM tender offers |
| Invesco Asia Trust PLC | AGM |
| LendInvest PLC | AGM |
| Lindsell Train Investment Trust PLC | AGM |
| Montanaro European Smaller Cos Trust PLC | AGM |
| ScotGems PLC | GM re voluntary liquidation |
| Semper Fortis Esports PLC | AGM |
| Severfield PLC | AGM |
| Speedy Hire PLC | AGM |
| SysGroup PLC | AGM |
| WH Ireland Group PLC | AGM |
| XPS Pensions Group PLC | AGM |
| Friday 9 September | |
Baillie Gifford UK Growth Trust PLC | AGM |
| CLS Holdings PLC | GM re tender offer |
| Gear4Music Holdings PLC | AGM |
| Newcrest Mining Ltd | AGM |
| Pensana PLC | AGM |
| ReNeuron Group PLC | AGM |
| SVM UK Emerging Fund PLC | AGM |
| Victoria Oil & Gas PLC | AGM |
| Voyager Life PLC | AGM |
| Copyright 2022 Alliance News Limited. All Rights Reserved. | |
1 Aug 2022 14:30
EXECUTIVE CHANGES: ReNeuron promotes CFO Catherine Isted to CEO role
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:
Read more4 Jul 2022 10:22
IN BRIEF: ReNeuron annual loss narrows amid shift in strategy
ReNeuron Group PLC - Bridgend, Wales-based stem cell and exosomes technology company - Pretax loss in year to March 31 narrows to GBP11.1 million from GBP13.4 million loss a year prior. Research & development costs fall to GBP8.1 million from GBP9.5 million, with general & administrative costs at GBP3.6 million versus GBP3.7 million. Revenue drops to GBP403,000 from GBP257,000.
Read more1 Jul 2022 13:40
IN BRIEF: ReNeuron inks deal worth up to GBP6 million in revenue
ReNeuron Group PLC - Bridgend, Wales-based stem cell and exosomes technology company - Negotiates a supplemental terms agreement with Shanghai Fosun Pharmaceutical Group Co Ltd. Company says the agreement has the potential to generate revenue of up to GBP6 million.
Read more27 Jun 2022 15:53
UK earnings, trading statements calendar - next 7 days
| Tuesday 28 June | |
| Appreciate Group PLC | Full Year Results |
| ICG Enterprise Trust PLC | Q1 Results |
| IG Design Group PLC | Full Year Results |
| Marlowe PLC | Full Year Results |
| Oxford BioDynamics PLC | Half Year Results |
| Petrofac Ltd | Trading Statement |
| Wise PLC | Full Year Results |
| Wednesday 29 June | |
| B&M European Value Retail SA | Q1 Results |
| LendInvest PLC | Full Year Results |
| Moonpig Group PLC | Full Year Results |
| Inspecs Group PLC | Full Year Results |
| Mulberry Group PLC | Full Year Results |
| ProCook Group PLC | Full Year Results |
| Thursday 30 June | |
| Accsys Technologies PLC | Full Year Results |
| Breedon Group PLC | Half Year Results |
| Bunzl PLC | Trading Statement |
| Civitas Social Housing PLC | Full Year Results |
| HgCapital Trust PLC | Half Year Results |
| Hunting PLC | Trading Statement |
| Polar Capital Holdings PLC | Full Year Results |
| PCF Group PLC | Full Year Results |
| Renalytix PLC | Q3 Results |
| SDCL Energy Efficiency Income Trust PLC | Full Year Results |
| SEEEN PLC | Full Year Results |
| Friday 1 July | |
| no events scheduled | |
| Monday 4 July | |
| Augmentum Fintech PLC | Full Year Results |
| Porvair PLC | Half Year Results |
| ReNeuron Group PLC | Full Year Results |
| Copyright 2022 Alliance News Limited. All Rights Reserved. | |
11 Feb 2022 13:50
IN BRIEF: ReNeuron chair steps in to run business as CEO resigns
ReNeuron Group PLC - Bridgend, Wales-based stem cell and exosomes technology - Olav Hellobo resigns as chief executive officer after seven years and will leave at the end of February. Hellobo says he decided it was time to leave following ReNeuron's recent change in strategy. The company has shifted its focus to the development of its exosomes technology platform. The platform uses stem cell technologies to develop "off the shelf" treatments for diseases. Chair Iain Ross, supported by Chief Financial Officer Catherine Isted, will run the business, ReNeuron says.
Read more18 Jan 2022 10:58
AIM WINNERS & LOSERS: Sanderson Design lifts outlook, Gattaca lowers
AIM WINNERS & LOSERS: Sanderson Design lifts outlook, Gattaca lowers
Read more18 Jan 2022 10:26
ReNeuron shares dive as it drops retinitis pigmentosa trials
ReNeuron shares dive as it drops retinitis pigmentosa trials
Read more13 Jan 2022 21:12
TRADING UPDATES: Power Metal renewal; Yamana production hits target
TRADING UPDATES: Power Metal renewal; Yamana production hits target
Read more11 Jan 2022 16:00
ReNeuron re-appoints Randolph Corteling in senior research role
ReNeuron re-appoints Randolph Corteling in senior research role
Read more30 Nov 2021 19:13
TRADING UPDATES: Zambeef sales continue climb; Watchstone files claim
TRADING UPDATES: Zambeef sales continue climb; Watchstone files claim
Read more